Synergistic cytotoxicity in pancreatic cancer: HDAC, PARP inhibitors, and decitabine show promise
A new research paper was published in Oncotarget's Volume 15 on June 3, 2024, entitled, "Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel …